150 related articles for article (PubMed ID: 1606721)
1. Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.
Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J
Clin Exp Immunol; 1992 Jun; 88(3):394-8. PubMed ID: 1606721
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy.
Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J
Clin Nephrol; 1993 Sep; 40(3):131-6. PubMed ID: 8403566
[TBL] [Abstract][Full Text] [Related]
3. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy.
Layward L; Finnemore AM; Allen AC; Harper SJ; Feehally J
Clin Immunol Immunopathol; 1993 Dec; 69(3):306-13. PubMed ID: 8242901
[TBL] [Abstract][Full Text] [Related]
4. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
5. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.
Leung JC; Tang SC; Chan LY; Tsang AW; Lan HY; Lai KN
Nephrol Dial Transplant; 2003 Jan; 18(1):36-45. PubMed ID: 12480958
[TBL] [Abstract][Full Text] [Related]
6. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
Chen A; Sheu LF; Ding SL; Lee WH
Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
[TBL] [Abstract][Full Text] [Related]
7. Response to mucosal antigen challenge in IgA nephropathy.
Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
Exp Nephrol; 1995; 3(5):300-7. PubMed ID: 7583052
[TBL] [Abstract][Full Text] [Related]
8. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
9. Complement-C1q TNF-Related Protein 3 Alleviates Mesangial Cell Activation and Inflammatory Response Stimulated by Secretory IgA.
Zhang R; Zhong L; Zhou J; Peng Y
Am J Nephrol; 2016; 43(6):460-8. PubMed ID: 27309491
[TBL] [Abstract][Full Text] [Related]
10. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89.
van Zandbergen G; van Kooten C; Mohamad NK; Reterink TJ; de Fijter JW; van de Winkel JG; Daha MR
Nephrol Dial Transplant; 1998 Dec; 13(12):3058-64. PubMed ID: 9870466
[TBL] [Abstract][Full Text] [Related]
11. T-cell homing receptor expression in IgA nephropathy.
Batra A; Smith AC; Feehally J; Barratt J
Nephrol Dial Transplant; 2007 Sep; 22(9):2540-8. PubMed ID: 17452405
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy.
Barratt J; Bailey EM; Buck KS; Mailley J; Moayyedi P; Feehally J; Turney JH; Crabtree JE; Allen AC
Am J Kidney Dis; 1999 Jun; 33(6):1049-57. PubMed ID: 10352192
[TBL] [Abstract][Full Text] [Related]
13. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.
Schena PF; Pastore A; Sinico RA; Montinaro V; Fornasieri A
J Immunol; 1988 Jul; 141(1):125-30. PubMed ID: 3379302
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA--role of MAPK and NF-kappaB.
Leung JC; Tang SC; Chan LY; Chan WL; Lai KN
Nephrol Dial Transplant; 2008 Jan; 23(1):72-81. PubMed ID: 17898021
[TBL] [Abstract][Full Text] [Related]
15. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
Smith AC; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune response after mucosal immunization in patients with IgA nephropathy.
Waldo FB
J Clin Immunol; 1992 Jan; 12(1):21-6. PubMed ID: 1551939
[TBL] [Abstract][Full Text] [Related]
17. A polymeric IgA response in serum can be produced by parenteral immunization.
Mascart-Lemone F; Duchateau J; Conley ME; Delacroix DL
Immunology; 1987 Aug; 61(4):409-13. PubMed ID: 3443449
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy.
Schena FP; Scivittaro V; Ranieri E; Sinico R; Benuzzi S; Di Cillo M; Aventaggiato L
Clin Exp Immunol; 1993 Apr; 92(1):139-44. PubMed ID: 8467558
[TBL] [Abstract][Full Text] [Related]
19. Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.
Eijgenraam JW; Oortwijn BD; Kamerling SW; de Fijter JW; van den Wall Bake AW; Daha MR; van Kooten C
Clin Exp Immunol; 2008 May; 152(2):227-32. PubMed ID: 18336594
[TBL] [Abstract][Full Text] [Related]
20. Polymeric IgA and immune complex concentrations in IgA-related renal disease.
Jones CL; Powell HR; Kincaid-Smith P; Roberton DM
Kidney Int; 1990 Aug; 38(2):323-31. PubMed ID: 2205751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
